Shire welcomes Adderall generic ruling

27-03-2018

Shire welcomes Adderall generic ruling

A US judge handed a win to Shire late last week, finding that a generic version of its attention deficit hyperactivity disorder drug Adderall XR (amphetamine/dextroamphetamine mixed salts) would infringe Shire’s patents.


Shire, generic, Adderall, ADHD, attention deficit hyperactivity disorder, Abhai, ANDA, litigation, ruling

More on this story

Takeda mulls Shire acquisition bid
03-04-2018

LSIPR